IL92264A - A process for the expression of recombinant genes containing codons for arginine AGA and / or GGA in ILOC bacteria. E - Google Patents

A process for the expression of recombinant genes containing codons for arginine AGA and / or GGA in ILOC bacteria. E

Info

Publication number: IL92264A
Authority: IL; Israel
Prior art keywords: gene; rna; expression; process according; coli
Prior art date: 1988-11-11

Application number

IL9226489A

Other languages

English (en)

Hebrew (he)

Other versions

IL92264A0 (en

Original Assignee

Boehringer Mannheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-11

Filing date

1989-11-09

Publication date

1994-08-31

1989-09-25 Priority claimed from DE19893931933 external-priority patent/DE3931933A1/de

1989-11-09 Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh

1990-07-26 Publication of IL92264A0 publication Critical patent/IL92264A0/xx

1994-08-31 Publication of IL92264A publication Critical patent/IL92264A/en

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 135
241000588724 Escherichia coli Species 0.000 title claims abstract description 46
108020004705 Codon Proteins 0.000 title claims abstract description 28
239000004475 Arginine Substances 0.000 title claims abstract description 26
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title claims abstract description 26
238000000034 method Methods 0.000 title claims description 38
230000008569 process Effects 0.000 title claims description 34
239000013612 plasmid Substances 0.000 claims abstract description 61
239000013604 expression vector Substances 0.000 claims abstract description 28
230000009466 transformation Effects 0.000 claims abstract description 8
210000004027 cell Anatomy 0.000 claims description 50
239000013598 vector Substances 0.000 claims description 19
108091034117 Oligonucleotide Proteins 0.000 claims description 11
108020005091 Replication Origin Proteins 0.000 claims description 6
239000002299 complementary DNA Substances 0.000 claims description 6
210000000349 chromosome Anatomy 0.000 claims description 5
108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
230000002759 chromosomal effect Effects 0.000 claims description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
241000588722 Escherichia Species 0.000 claims description 2
238000012761 co-transfection Methods 0.000 claims description 2
241000193830 Bacillus <bacterium> Species 0.000 claims 2
240000005020 Acaciella glauca Species 0.000 claims 1
241000807025 Nilus Species 0.000 claims 1
108700026220 vif Genes Proteins 0.000 claims 1
230000006698 induction Effects 0.000 abstract description 4
108050006955 Tissue-type plasminogen activator Proteins 0.000 description 30
102100033571 Tissue-type plasminogen activator Human genes 0.000 description 29
239000012634 fragment Substances 0.000 description 18
102000004169 proteins and genes Human genes 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 10
239000013613 expression plasmid Substances 0.000 description 7
229930027917 kanamycin Natural products 0.000 description 5
229960000318 kanamycin Drugs 0.000 description 5
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
229930182823 kanamycin A Natural products 0.000 description 5
238000004458 analytical method Methods 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
108020004414 DNA Proteins 0.000 description 3
238000010367 cloning Methods 0.000 description 3
239000000523 sample Substances 0.000 description 3
108020005098 Anticodon Proteins 0.000 description 2
241000193385 Geobacillus stearothermophilus Species 0.000 description 2
108010054278 Lac Repressors Proteins 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
108020004566 Transfer RNA Proteins 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
239000002028 Biomass Substances 0.000 description 1
241000283707 Capra Species 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
101150017040 I gene Proteins 0.000 description 1
206010061216 Infarction Diseases 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
229930185560 Pseudouridine Natural products 0.000 description 1
PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
241000382353 Pupa Species 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000009661 Repressor Proteins Human genes 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
102100027208 T-cell antigen CD7 Human genes 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000008901 benefit Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000003501 co-culture Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000007574 infarction Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
108010073863 saruplase Proteins 0.000 description 1
238000009210 therapy by ultrasound Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Medicinal Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Fats And Perfumes (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

IL9226489A 1988-11-11 1989-11-09 A process for the expression of recombinant genes containing codons for arginine AGA and / or GGA in ILOC bacteria. E IL92264A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE3838378		1988-11-11
DE3928899		1989-08-31
DE19893931933 DE3931933A1 (de)	1988-11-11	1989-09-25	Verfahren zur expression eines eukaryontischen gens

Publications (2)

Publication Number	Publication Date
IL92264A0 IL92264A0 (en)	1990-07-26
IL92264A true IL92264A (en)	1994-08-31

Family

ID=27198503

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9226489A IL92264A (en)	1988-11-11	1989-11-09	A process for the expression of recombinant genes containing codons for arginine AGA and / or GGA in ILOC bacteria. E

Country Status (10)

Country	Link
US (1)	US6270988B1 (fr)
EP (1)	EP0373365B1 (fr)
JP (1)	JP2619077B2 (fr)
AT (1)	ATE105863T1 (fr)
AU (1)	AU618640B2 (fr)
CA (1)	CA2002516C (fr)
DE (1)	DE58907690D1 (fr)
DK (1)	DK175456B1 (fr)
ES (1)	ES2053917T3 (fr)
IL (1)	IL92264A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2261913C1 (ru) *	2004-01-15	2005-10-10	Институт биоорганической химии им.академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук	РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pES6-1, КОДИРУЮЩАЯ ПОЛИПЕПТИД ИНТЕРФЕРОН БЕТА-1b ЧЕЛОВЕКА, И ШТАММ Escherichia coli BDEES6 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА БЕТА-1b ЧЕЛОВЕКА

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3838377A1 (de) *	1988-11-11	1990-05-23	Boehringer Mannheim Gmbh	Expressions-enhancer und dessen verwendung zur erhoehung der ausbeute bei der expression von rekombinanten genen
CA2360352A1 (fr) *	1999-01-27	2000-08-03	Stratagene	Compositions et procedes pour l'expression a haut niveau d'une proteine heterologue a codons rares
AU2001249170A1 (en) *	2000-03-13	2001-09-24	Aptagen	Method for modifying a nucleic acid
US6821755B2 (en)	2000-07-27	2004-11-23	Boehringer Ingelheim International Gmbh	Preparation of a recombinant protein in a prokaryotic host cell
DE10037111A1 (de) *	2000-07-27	2002-02-07	Boehringer Ingelheim Int	Herstellung eines rekombinanten Proteins in einer prokaryontischen Wirtszelle
US7125703B2 (en)	2001-03-13	2006-10-24	Dendreon Corporation	Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
US7172892B2 (en)	2001-03-22	2007-02-06	Dendreon Corporation	Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
JP2005506047A (ja)	2001-03-27	2005-03-03	デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー	膜貫通型セリンプロテアーゼ９をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法
US7112430B2 (en)	2001-05-14	2006-09-26	Dendreon Corporation	Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
US20030134298A1 (en) *	2001-07-03	2003-07-17	Madison Edwin L.	Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
IL159944A0 (en) *	2001-07-19	2004-06-20	Yissum Res Dev Co	Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
US20030134794A1 (en) *	2001-11-20	2003-07-17	Madison Edwin L.	Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
EP1723236A1 (fr)	2004-03-03	2006-11-22	F.Hoffmann-La Roche Ag	Procede d'expression recombinante d'un fragment n-terminal du facteur de croissance d'hepatocyte
DE602007007612D1 (de) *	2006-04-22	2010-08-19	Scarab Genomics Llc	Verfahren und zusammensetzungen zur herstellung rekombinanter proteine unter verwendung eines gens für trna
JP4886654B2 (ja) *	2007-10-29	2012-02-29	日本ケミカルリサーチ株式会社	ヒト成長ホルモンの効率化された製造方法
KR101147860B1 (ko)	2008-09-22	2012-05-25	한국과학기술원	특정 아미노산의 ｔＲＮＡ와의 동시 발현을 통한 특정 아미노산 함량이 높은 단백질의 제조방법
KR101317420B1 (ko) *	2010-03-11	2013-10-10	한국과학기술원	고분자량의 재조합 실크 또는 실크 유사 단백질 및 이를 이용하여 제조된 마이크로 또는 나노 크기의 거미줄 또는 거미줄 유사 섬유

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4673641A (en) *	1982-12-16	1987-06-16	Molecular Genetics Research And Development Limited Partnership	Co-aggregate purification of proteins
US4654307A (en) *	1983-02-17	1987-03-31	The Research Foundation Of State University Of New York	Novel bacteria containing a plasmid having a tRNA code
SE455704B (sv) *	1983-10-24	1988-08-01	Ac Biotechnics Ab	Bakteriecell innehallande plasmid med stabiliserad nedervning, plasmid samt forfarande for framstellning av bakteriecellen
US5145776A (en) *	1987-01-14	1992-09-08	President & Fellows Of Harvard College	Method of using T7 DNA polymerase to mutagenize and fill-in DNA
US4970147A (en) *	1988-03-17	1990-11-13	The General Hospital Corporation	Oxygen regulatable gene expression

1989
- 1989-11-06 AU AU44443/89A patent/AU618640B2/en not_active Ceased
- 1989-11-08 CA CA002002516A patent/CA2002516C/fr not_active Expired - Lifetime
- 1989-11-09 IL IL9226489A patent/IL92264A/en unknown
- 1989-11-10 EP EP89120895A patent/EP0373365B1/fr not_active Expired - Lifetime
- 1989-11-10 DE DE58907690T patent/DE58907690D1/de not_active Expired - Lifetime
- 1989-11-10 AT AT89120895T patent/ATE105863T1/de not_active IP Right Cessation
- 1989-11-10 ES ES89120895T patent/ES2053917T3/es not_active Expired - Lifetime
- 1989-11-10 DK DK564789A patent/DK175456B1/da not_active IP Right Cessation
- 1989-11-13 JP JP1292539A patent/JP2619077B2/ja not_active Expired - Lifetime
1993
- 1993-01-27 US US08/009,423 patent/US6270988B1/en not_active Expired - Lifetime

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2261913C1 (ru) *	2004-01-15	2005-10-10	Институт биоорганической химии им.академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук	РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pES6-1, КОДИРУЮЩАЯ ПОЛИПЕПТИД ИНТЕРФЕРОН БЕТА-1b ЧЕЛОВЕКА, И ШТАММ Escherichia coli BDEES6 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА БЕТА-1b ЧЕЛОВЕКА

Also Published As

Publication number	Publication date
JPH02265490A (ja)	1990-10-30
DK564789A (da)	1990-05-12
EP0373365B1 (fr)	1994-05-18
EP0373365A1 (fr)	1990-06-20
AU618640B2 (en)	1992-01-02
AU4444389A (en)	1990-11-08
CA2002516A1 (fr)	1990-05-11
US6270988B1 (en)	2001-08-07
IL92264A0 (en)	1990-07-26
DK564789D0 (da)	1989-11-10
ATE105863T1 (de)	1994-06-15
JP2619077B2 (ja)	1997-06-11
ES2053917T3 (es)	1994-08-01
DK175456B1 (da)	2004-11-01
CA2002516C (fr)	1995-10-31
DE58907690D1 (de)	1994-06-23

Legal Events

Date	Code	Title
1996-03-31	KB	Patent renewed
2000-07-26	KB	Patent renewed
2000-08-31	KB	Patent renewed
2004-01-04	KB	Patent renewed
2008-01-06	KB	Patent renewed

Publication	Publication Date	Title
CA2002516C (fr)	1995-10-31	Procede d'expression de genes recombinants
JP3801389B2 (ja)	2006-07-26	栄養要求性を相補することによる、抗生物質によらない選抜に基づく新規の大腸菌／宿主ベクター系
Carter-Muenchau et al.	1989	Growth-rate-dependent regulation of 6-phosphogluconate dehydrogenase level mediated by an anti-Shine-Dalgarno sequence located within the Escherichia coli gnd structural gene.
FI86746B (fi)	1992-06-30	Foerfarande foer framstaellning av maensklig vaevnads-plasminogenaktivator (tpa) med hjaelp av saccharomyces cerevisiae -jaest och i foerfarandet anvaenda hybridvektorer.
AU608572B2 (en)	1991-04-11	Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase and deacetylcephalosporin c synthetase
JP2544602B2 (ja)	1996-10-16	新規プラスミドベクタ−
KR0167761B1 (ko)	1999-01-15	플라스미드, 이의 작제방법 및 플라스미노겐 활성자 제조에 있어서의 이의 용도
AU640654B2 (en)	1993-09-02	Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
US5756313A (en)	1998-05-26	Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
Hottinger et al.	1987	Allele-specific complementation of an Escherichia coli leuB mutation by a Lactobacillus bulgaricus tRNA gene
EP0186069B1 (fr)	1992-02-19	Séquence de contrôle d'expression
CA2622710C (fr)	2016-10-18	Origine transferable hybride de plasmides a replication
CA2012632C (fr)	1998-07-28	Procede pour l'expression de genes recombinants
CA2002515C (fr)	1996-03-19	Stimulateur de l'expression et son utilisation pour augmenter le rendement dans l'expression de genes recombinants
US5160489A (en)	1992-11-03	Expression vectors and method for their construction
EP0154351B1 (fr)	1991-08-14	Plasmides d'expression utilisables dans le bacillus subtilis
AU601420B2 (en)	1990-09-13	Process for the production of plasminogen activators in procaryotes
JP3877861B2 (ja)	2007-02-07	高発現ベクタープラスミド用ｄｎａ断片
Nicholls et al.	1987	Repressor gene, blaI, for Bacillus licheniformis 749 β‐lactamase
DE3931933A1 (de)	1990-05-17	Verfahren zur expression eines eukaryontischen gens
JPS63133988A (ja)	1988-06-06	変形された組織プラスミノ−ゲンアクチベ−タ−
MXPA99006530A (en)	2000-11-01	Novel escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
JPH02138982A (ja)	1990-05-28	ベクター

IL92264A - A process for the expression of recombinant genes containing codons for arginine AGA and / or GGA in ILOC bacteria. E - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (3)

Publications (2)

Family

ID=27198503

Family Applications (1)

Country Status (10)

Cited By (1)

Families Citing this family (17)

Family Cites Families (5)

Cited By (1)

Also Published As

Similar Documents

Legal Events